Author:
Shilkrut Mark,Merrick Gregory S.,McLaughlin P. William,Stenmark Matthew H.,Abu-Isa Eyad,Vance Sean M.,Sandler Howard M.,Feng Felix Y.,Hamstra Daniel A.
Reference31 articles.
1. Cancer statistics, 2012;Siegel;CA Cancer J Clin.,2012
2. Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma-long-term results of phase III RTOG 85-31;Pilepich;Int J Radiat Oncol Biol Phys.,2005
3. High-risk prostate cancer in the United States, 1990-2007;Cooperberg;World J Urol.,2010
4. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer;Kupelian;Int J Radiat Oncol Biol Phys.,2004
5. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial;Widmark;Lancet.,2009